KEI-NIH FOIA Lawsuit for Francis Collins Correspondence - May 2022 Production
Bookreader Item Preview
Share or Embed This Item
texts
KEI-NIH FOIA Lawsuit for Francis Collins Correspondence - May 2022 Production
- Publication date
- 2022-05-16
- Topics
- KEI FOIA request, NIH FOIA, KEI-NIH FOIA request, KEI-NIH FOIA lawsuit, National Institutes of Health, NIH, Foundation for the National Institutes of Health, FNIH, BIO, PhRMA, Gilead, Roche, Genentech, Novartis, Biden Cancer Initiative, Accelerating Medicines Partnership, AMP, Charles Sawyer, Carl Icahn, Patrick Soon-Shiong, KEI FOIA 47589, NIH FOIA 47589
- Collection
- knowledgeecologyinternational; americana
- Language
- English
- Item Size
- 311.9M
May 2022 production of records in the KEI-NIH Freedom of Information Act (FOIA) lawsuit regarding an April 16, 2018 FOIA request for correspondence between then-NIH Director Francis Collins and representatives of the pharmaceutical industry and surrounding entities.
This request sought Dr. Collins' correspondences with persons representing the Foundation for the NIH (FNIH), Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead, Roche, Genentech, Novartis, the Biden Cancer Initiative, certain individuals: Charles Sawyer, Carl Icahn, and Patrick Soon-Shiong, and members of the Accelerating Medicines Partnership (AMP) (a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), 12 biopharmaceutical and life science companies and 13 non-profit organizations).
This request sought Dr. Collins' correspondences with persons representing the Foundation for the NIH (FNIH), Biotechnology Innovation Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA), Gilead, Roche, Genentech, Novartis, the Biden Cancer Initiative, certain individuals: Charles Sawyer, Carl Icahn, and Patrick Soon-Shiong, and members of the Accelerating Medicines Partnership (AMP) (a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), 12 biopharmaceutical and life science companies and 13 non-profit organizations).
- Addeddate
- 2023-02-02 17:14:26
- Identifier
- kei-nih-foia-collins-correspondence-may-2022-production
- Identifier-ark
- ark:/13960/s2mbm2bw6zc
- Ocr
- tesseract 5.3.0-1-gd3a4
- Ocr_detected_lang
- en
- Ocr_detected_lang_conf
- 1.0000
- Ocr_detected_script
- Latin
- Ocr_detected_script_conf
- 0.9621
- Ocr_module_version
- 0.0.18
- Ocr_parameters
- -l eng
- Page_number_confidence
- 37.95
- Ppi
- 147
- Scanner
- Internet Archive HTML5 Uploader 1.7.0
- Type
- correspondence
comment
Reviews
There are no reviews yet. Be the first one to
write a review.
188 Views
DOWNLOAD OPTIONS
DAISY
Uplevel BACK
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%201_daisy.zip
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%202_daisy.zip
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%203_daisy.zip
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%204_daisy.zip
Temporarily Unavailable
Temporarily Unavailable
Temporarily Unavailable
Temporarily Unavailable
For users with print-disabilities
EPUB
Uplevel BACK
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%201.epub
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%202.epub
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%203.epub
KEI-NIH%20FOIA%20Collins%20Correspondence%20May%202022%20Production%20Part%204.epub
Temporarily Unavailable
Temporarily Unavailable
Temporarily Unavailable
Temporarily Unavailable
OCR SEARCH TEXT
Uplevel BACK
62.3K
KEI-NIH FOIA Collins Correspondence May 2022 Production Part 1_hocr_searchtext.txt.gz download
63.9K
KEI-NIH FOIA Collins Correspondence May 2022 Production Part 2_hocr_searchtext.txt.gz download
IN COLLECTIONS
Knowledge Ecology InternationalUploaded by Knowledge Ecology International on